IRIS Accounts Production v26.1.10.60 13659884 Board of Directors 1.12.24 30.11.25 30.11.25 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh136598842024-11-30136598842025-11-30136598842024-12-012025-11-30136598842023-11-30136598842023-12-012024-11-30136598842024-11-3013659884ns15:EnglandWales2024-12-012025-11-3013659884ns14:PoundSterling2024-12-012025-11-3013659884ns10:Director12024-12-012025-11-3013659884ns10:PrivateLimitedCompanyLtd2024-12-012025-11-3013659884ns10:SmallEntities2024-12-012025-11-3013659884ns10:AuditExempt-NoAccountantsReport2024-12-012025-11-3013659884ns10:SmallCompaniesRegimeForDirectorsReport2024-12-012025-11-3013659884ns10:SmallCompaniesRegimeForAccounts2024-12-012025-11-3013659884ns10:FullAccounts2024-12-012025-11-3013659884ns10:Director22024-12-012025-11-3013659884ns10:RegisteredOffice2024-12-012025-11-3013659884ns5:CurrentFinancialInstruments2025-11-3013659884ns5:CurrentFinancialInstruments2024-11-3013659884ns5:Non-currentFinancialInstruments2025-11-3013659884ns5:Non-currentFinancialInstruments2024-11-3013659884ns5:ShareCapital2025-11-3013659884ns5:ShareCapital2024-11-3013659884ns5:RetainedEarningsAccumulatedLosses2025-11-3013659884ns5:RetainedEarningsAccumulatedLosses2024-11-3013659884ns5:PlantMachinery2024-12-012025-11-3013659884ns5:PlantMachinery2024-11-3013659884ns5:PlantMachinery2025-11-3013659884ns5:PlantMachinery2024-11-3013659884ns5:CostValuation2024-11-3013659884ns5:AdditionsToInvestments2025-11-3013659884ns5:RevaluationsIncreaseDecreaseInInvestments2025-11-3013659884ns5:CostValuation2025-11-3013659884ns5:WithinOneYearns5:CurrentFinancialInstruments2025-11-3013659884ns5:WithinOneYearns5:CurrentFinancialInstruments2024-11-30
REGISTERED NUMBER: 13659884 (England and Wales)



















Unaudited Financial Statements

for the Year Ended 30 November 2025

for

Stumpfle Medical Limited

Stumpfle Medical Limited (Registered number: 13659884)

Contents of the Financial Statements
for the Year Ended 30 November 2025










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


Stumpfle Medical Limited

Company Information
for the Year Ended 30 November 2025







DIRECTORS: Dr M Stumpfle
Dr R Stumpfle





REGISTERED OFFICE: 44 The Pantiles
Tunbridge Wells
Kent
TN2 5TN





REGISTERED NUMBER: 13659884 (England and Wales)





ACCOUNTANTS: APT
44 The Pantiles
Tunbridge Wells
Kent
TN2 5TN

Stumpfle Medical Limited (Registered number: 13659884)

Balance Sheet
30 November 2025

30.11.25 30.11.24
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 15,392 19,246
Investments 5 271,054 154,500
286,446 173,746

CURRENT ASSETS
Debtors 6 27,350 22,842
Cash at bank 152,738 107,620
180,088 130,462
CREDITORS
Amounts falling due within one year 7 66,998 49,976
NET CURRENT ASSETS 113,090 80,486
TOTAL ASSETS LESS CURRENT
LIABILITIES

399,536

254,232

CREDITORS
Amounts falling due after more than one
year

8

(9,391

)

(17,238

)

PROVISIONS FOR LIABILITIES (7,987 ) -
NET ASSETS 382,158 236,994

CAPITAL AND RESERVES
Called up share capital 200 200
Retained earnings 381,958 236,794
382,158 236,994

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 November 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 November 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Stumpfle Medical Limited (Registered number: 13659884)

Balance Sheet - continued
30 November 2025


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 21 May 2026 and were signed on its behalf by:





Dr R Stumpfle - Director


Stumpfle Medical Limited (Registered number: 13659884)

Notes to the Financial Statements
for the Year Ended 30 November 2025


1. STATUTORY INFORMATION

Stumpfle Medical Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention as modified by the revaluation of certain assets.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery etc - 20% on reducing balance and 20% on cost

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Going concern
After reviewing the company's forecasts and projections, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. The company therefore continues to adopt the going concern basis in preparing its financial statements.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2024 - 2 ) .

Stumpfle Medical Limited (Registered number: 13659884)

Notes to the Financial Statements - continued
for the Year Ended 30 November 2025


4. TANGIBLE FIXED ASSETS
Plant and
machinery
etc
£   
COST
At 1 December 2024
and 30 November 2025 28,865
DEPRECIATION
At 1 December 2024 9,619
Charge for year 3,854
At 30 November 2025 13,473
NET BOOK VALUE
At 30 November 2025 15,392
At 30 November 2024 19,246

5. FIXED ASSET INVESTMENTS
Other
investments
£   
COST OR VALUATION
At 1 December 2024 154,500
Additions 100,000
Revaluations 16,554
At 30 November 2025 271,054
NET BOOK VALUE
At 30 November 2025 271,054
At 30 November 2024 154,500

Cost or valuation at 30 November 2025 is represented by:

Other
investments
£   
Valuation in 2025 16,554
Cost 254,500
271,054

Stumpfle Medical Limited (Registered number: 13659884)

Notes to the Financial Statements - continued
for the Year Ended 30 November 2025


5. FIXED ASSET INVESTMENTS - continued

If the fixed asset investments had not been revalued it would have been included at the following historical cost:

30.11.25 30.11.24
£    £   
Cost 254,500 -

Fixes asset investments were valued on an encashment value basis on 10 November 2025 by St James Place .

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30.11.25 30.11.24
£    £   
Trade debtors 27,350 20,412
Other debtors - 2,430
27,350 22,842

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30.11.25 30.11.24
£    £   
Taxation and social security 60,699 48,201
Other creditors 6,299 1,775
66,998 49,976

8. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
30.11.25 30.11.24
£    £   
Hire purchase contracts 9,391 17,238

9. RELATED PARTY DISCLOSURES

At the balance sheet date the company owed its directors £325 (2024 £nil).